Xeltis is revolutionizing the treatment of heart valve disease. In a process called Endogenous Tissue Restoration (ETR), the patient’s natural healing system develops tissue that pervades Xeltis’ implant, forming a new, natural and fully functional heart valve. As ETR occurs, Xeltis’ heart valves are gradually absorbed by the body.
Xeltis is leveraging breakthrough science to transform heart valve treatment – making the seemingly impossible, possible.
Xeltis’ heart valves have a porous structure made of polymers, based on Nobel-prize awarded science.
The latest generation of supramolecular polymers are strong and flexible enough to meet the requirements of a beating heart.